Office of Commercialization Published Technologies
Self-Operable Non-Invasive Fully-Automated Biomedical Device for Vital Signs Monitoring

Self-Operable Non-Invasive Fully-Automated Biomedical Device for Vital Signs Monitoring

Description:

Abstract

According to the Centers for Disease Control and Prevention, an average of 600,000 people die of heart disease in the U.S. every year (1 in every 4 deaths). Similar statistics are present globally, where about 35 percent of deaths are due to cardiovascular diseases. More than half of those deaths occurred in a hospital emergency room or before the patient reached the hospital. Many lives can be saved by providing patients and doctors with cardiovascular activity data; however, the current process is cumbersome to patients and time consuming to doctors.

 

Researchers at WSU have developed a novel cardiovascular monitoring technology that will allow for consistent and reliable monitoring of cardiovascular activity. The technology is a fully-automated, removeable, and self-operable biomedical device that monitors vital signs and requires minimal medical assistance to function properly.

 

Applications and Advantages

•Require no ‘prepping’ or a dedicated medical resource

•Generate diagnostic quality measurement

•Tolerate motion artifacts even in standing posture

•Perform long-term recording and signal transmission

•Reduce the backlog of patients at medical clinics, emergency response and rural areas by transmitting information digitally and securely for both consulting and diagnosis

Patent Information: